Status:
RECRUITING
A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea
Lead Sponsor:
Janssen Korea, Ltd., Korea
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
Up to 17 years
Brief Summary
The purpose of this study is: * to find out out the number of children who develop crohn's disease (CD) and ulcerative colitis (UC) each year and are living with the disease and to see how this diffe...
Eligibility Criteria
Inclusion Criteria:
- Participants with at least two outpatient or one inpatient diagnosis codes for the same disease type (either CD or UC) using international classification of diseases, tenth revision (ICD-10) codes (K50. X for CD and K51. X for UC) recorded as primary or the first secondary diagnosis, and the codes for rare and intractable disease registration program (V130 for CD, V131 for UC) during the index period
- Participants who received at least one prescription for conventional pediatric inflammatory bowel disease (IBD)-related medications (for example, 5-aminosalicylic acids [5-ASAs], exclusive enteral nutrition [EENs], corticosteroids, immunomodulators, or biologic drugs) during the index period
Exclusion Criteria:
- No specific exclusion criteria are defined in this study
Key Trial Info
Start Date :
April 7 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2026
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT07520747
Start Date
April 7 2026
End Date
June 20 2026
Last Update
April 13 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sungkyunkwan University Research and Business Foundation
Suwon, South Korea, 16419